Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
Investment Firms›
Charter Life Sciences
AddedFeb 17, 2024
UpdatedJun 28, 2026
Charter Life Sciences

Charter Life Sciences

Operating

Charter Life Sciences: A US-based venture capital firm specializing in early-stage clinical life science investments.

Location
Santa Clara, CA, US
Firm
Compare
Portfolio
Employees

Charter Life Sciences (CLS) operates as a venture capital firm.

The Company focuses on the early stage clinical life science companies such as medical device and drug development companies. CLS serves clients in the United States.

Charter Life Sciences - Portfolio Snapshot

Portfolio activity breakdown across disclosed investments and stages

Total Investments13
Current Portfolio Count6
Total Portfolio Exits2

Top Investment Stages

Series B7 (53.8%)
Series A3 (23.1%)
Series C1 (7.7%)
Series E1 (7.7%)
Series Unknown1 (7.7%)

Stage Mix

Series B 54%Series A 23%Series C 8%Series E 8%Series Unknown 8%

Concentration shown as share of disclosed investments by stage.

Recent Investments

Prevacept Infection Control logo

Prevacept Infection Control

Minimally Invasive Devices logo

Minimally Invasive Devices

Corepair logo

Corepair

CymaBay Therapeutics logo

CymaBay Therapeutics

APT Pharmaceuticals logo

APT Pharmaceuticals

Mirabilis Medica logo

Mirabilis Medica

KFx Medical logo

KFx Medical

Kereos logo

Kereos

Charter Life Sciences - Similar Investment Firms

Enso Ventures logo

Enso Ventures

Charter Venture Group logo

Charter Venture Group

CLI Ventures logo

CLI Ventures

LifeSci Venture Partners logo

LifeSci Venture Partners

lifesciventure.com

Life Science Angels logo

Life Science Angels

Synergy Life Science Partner logo

Synergy Life Science Partner

Charter Venture Capital logo

Charter Venture Capital

BioInnovation logo

BioInnovation

Accele Venture Partners logo

Accele Venture Partners

Cogene Ventures logo

Cogene Ventures

Advent Life Sciences logo

Advent Life Sciences

adventls.com

Lifeforce Capital logo

Lifeforce Capital

lifeforcecap.com

CHL Medical Partners logo

CHL Medical Partners

CTI Life Sciences Fund logo

CTI Life Sciences Fund

ctisciences.com

Lifespan Investments logo

Lifespan Investments

Charter Life Sciences - Classification

Also Known As
  • Charter Life Sciences LP
NAICS
  • 520000Finance and Insurance
  • 523000Securities, Commodity Contracts, and Other Financial Investments and Related Activities
  • 523900Other Financial Investment Activities
  • 523990All Other Financial Investment Activities
  • 523999Miscellaneous Financial Investment Activities
SIC
  • 6700Holding And Other Investment Offices
  • 6790Miscellaneous Investing
  • 6799Investors, Not Elsewhere Classified
Show 6 more industry codes
NAICS
  • 525000Funds, Trusts, and Other Financial Vehicles
  • 523910Miscellaneous Intermediation
  • 523940Portfolio Management and Investment Advice
SIC
  • 6000Depository Institutions
  • 6720Investment Offices
  • 6722Management Investment Offices, Open-end